The DGIST Center for Synapse Diversity and Specificity has identified MDGA2 as a novel causative gene for developmental and epileptic encephalopathy (DEE), a rare and intractable neurological disorder ...

SOUTH SAN FRANCISCO, Calif., February 02, 2026--insitro, the AI therapeutics company built on causal biology, today reported research demonstrating that artificial intelligence enables ...

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease, affecting more than ...

Scientists at Google DeepMind —the company’s artificial intelligence research arm—say they’ve created an A.I. tool that can ...

Our records of the human genome may still be missing tens of thousands of 'dark' genes. These hard-to-detect sequences of genetic material can code for tiny proteins, some involved in disease ...

Speech feels ordinary because it fills daily life, flowing through kitchens and waiting rooms without demanding attention. Words appear while hands stay busy, always carrying meaning with little ...

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...

The headline figure of lifespan being around “50% heritable” risks being misunderstood as meaning genes determine half of a ...

For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...

A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...